Craft

Coherus BioSciences

Stock Price

$1.7

2024-07-17

Market Capitalization

$199.6 M

2024-07-17

Revenue

$257.2 M

FY, 2023

Coherus BioSciences Summary

Company Summary

Overview
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. It offers immuno-oncology and biosimilar therapy solutions.
Type
Public
Status
Active
Founded
2010
HQ
Redwood City, CA, US | view all locations
Website
https://www.coherus.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Dennis M. Lanfear

    Dennis M. Lanfear, President, Chief Executive Officer and Chairman

    • Rosh Dias

      Rosh Dias, Chief Medical Officer

    • Richard L. Hameister

      Richard L. Hameister, Chief Technical Officer

    • Theresa Lavallee

      Theresa Lavallee, Chief Development Officer

    Operating MetricsView all

    Patent Families

    25

    FY, 2020

    Trials Products Approved

    1

    FY, 2020

    Phase II Trials Products

    1

    FY, 2020

    LocationsView all

    2 locations detected

    • Redwood City, CA HQ

      United States

      333 Twin Dolphin Dr #600

    • Camarillo, CA

      United States

      1000 Avenida Acaso

    Coherus BioSciences Financials

    Summary Financials

    Revenue (Q1, 2024)
    $77.1M
    Gross profit (Q1, 2024)
    $42.5M
    Net income (Q1, 2024)
    $102.9M
    Cash (Q1, 2024)
    $259.8M
    EBIT (Q1, 2024)
    ($42.5M)
    Enterprise value
    $114.8M

    Footer menu